Kinjal is part of the preclinical development team at Life Edit, focused on developing assays to assess genome editing technology.
Kinjal previously worked at StrideBio with the Analytical Development and Quality Control team. She was involved in AAV characterization and method development.
Kinjal Received her M.S. in Biotechnology from S. P. University of Gujarat, India. She is an ASCP certified molecular technologist.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
